BIOVIE INC.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 13, 2026
BIVI$1.30-2.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Changes in Stockholders’ Equity
For the Years Ended June 30, 2026 and 2025
| Additional · Total | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Paid in | Treasury Stock | Treasury Stock | Accumulated | Stockholders' | |
| Shares | Amount | Capital | Shares | Amount | Deficit | Equity | |
| Balance, June 30, 2024 | 621,640 | $62 | $349,738,841 | (2,633) | $(27) | $(334,232,661) | $15,506,215 |
| Stock - based compensation - stock options | - | - | 1,195,447 | - | - | - | 1,195,447 |
| Stock - based compensation - restricted stock units and restricted shares | - | - | 1,202,809 | - | - | - | 1,202,809 |
| Proceeds from issuance of common stock, net of costs of $3,240,288 | 988,394 | 99 | 15,674,514 | - | - | - | 15,674,613 |
| Issuance of common stock from vesting of restricted stock units | 11,314 | 7 | (5) | (203) | (2) | - | - |
| Stock-based compensation - issuance of common stock for services rendered | 6,000 | - | 73,680 | - | - | - | 73,680 |
| Issuance of common stock from exercise of warrants | 223,130 | 22 | 2,901,319 | - | - | - | 2,901,341 |
| Issuance of common stock from cashless exercise of warrants | 422 | - | - | - | - | - | - |
| Deemed dividend for ratchet adjustment to warrants | - | - | 369,465 | - | - | (369,465) | - |
| Issuance of additional shares for fractional shares effected by the reverse split | 66,161 | 2 | (2) | - | - | - | - |
| Net Loss | - | - | - | - | - | (17,542,120) | (17,542,120) |
| Balance, June 30, 2025 | 1,917,061 | $192 | $371,156,068 | (2,836) | $(29) | $(352,144,246) | $19,011,985 |
| Stock - based compensation - stock options | - | - | 2,283,809 | - | - | - | 2,283,809 |
| Stock - based compensation - restricted stock units and restricted shares | - | - | 589,710 | - | - | - | 589,710 |
| Proceeds from issuance of common stock, net of costs of $1,543,038 | 5,620,000 | 562 | 10,457,067 | - | - | - | 10,457,629 |
| Issuance of common stock from vesting of restricted stock units | 8,413 | - | - | - | - | - | - |
| Deemed dividend for ratchet adjustment to warrants | - | - | 43,544 | - | - | (43,544) | - |
| Net Loss | - | - | - | - | - | (22,072,863) | (22,072,863) |
| Balance, June 30, 2026 | 7,545,474 | $754 | $384,530,198 | (2,836) | $(29) | $(374,260,653) | $10,270,270 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.